Abstract
Objective: To investigate and describe the standardized medicine to treat alcohol hangover that are presented by scientific literature. Methods: Were developed a systematic review which aims to answer the question: "Which standardized medicines are presented by the scientific literature to treat alcohol Hangover". This study followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines and made a search in MEDLINE, Scielo, Web of Science, Latin American and Caribbean Health Sciences Literature with the descriptors “Alcohol hangover AND Treatment”. The PROSPERO number of this article is: CRD42024557119 Results: From the 425 found studies, two noted that Pyrithioxin and Propranolol did not reduce alcohol hangover symptoms. However, other four studies proposed that Chlormethiazole, Loxoprofen, SJP-001 and L-cysteine significantly reduced these symptoms effects of alcohol hangover. Final considerations: A wide range of treatment measures are presented in the literature, with few options appearing to have beneficial effects over alcohol hangover. Personal factors such as gender, age, ethnicity, and other conditions should be taken into consideration when evaluating the effects of a medication on alcohol hangover treatment.
References
ARESI, G., et al. Cultural Differences in Alcohol Consumption: The State of the Art and New Perspectives on Drinking Culture Research. 2021; 35: 80 - 88.
ERIKSON CJP, et al. L-Cysteine containing vitamin supplement which prevents or alleviates alcohol-related hangover symptoms: nausea, headache, stress and anxiety. Alcohol Alcohol. 2020; 55: 660-666.
GARCIA-CERDE R, et al. Alcohol use during the COVID-19 pandemic in Latin America and the Caribbean. Rev Panam Salud Publica. 2021; 20: 45-52.
GOBIN RM, et al. Propranolol for the treatment of alcoholic hangovers. Am J Drug Alcohol Abuse. 1987; 13: 175-180.
HARA M, et al. A nationwide randomized, double-blind, placebo-controlled physicians' trial of loxoprofen for the treatment of fatigue, headache, and nausea after hangovers. Alcohol. 2020; 84: 21-25.
KHAN MA, et al. Alcohol-induced hangover. A double-blind comparison of pyritinol and placebo in preventing hangover symptoms. Q J Stud Alcohol. 1973; 34: 114-128.
MANTHEY J, et al. What are the Economic Costs to Society Attributable to Alcohol Use? A Systematic Review and Modelling Study. Pharmacoeconomics. 2021; 39(7): 809-822.
MYRSTEN AL, et al. Alcohol intoxication and hangover: modification of hangover by chlormethiazole. Psychopharmacology. 1980; 69: 117-125.
OUZZANI M, et al. Rayyan—a web and mobile app for systematic reviews. Syst Rev. 2016; 5: 329-335.
PALMER E, et al. Alcohol hangover: underlying biochemical, inflammatory and neurochemical mechanisms. Alcohol. 2019; 54: 196-203.
ROCHE A, et al. Alcohol and drug-related absenteeism: a costly problem. Aust N Z J Public Health. 2015; 39: 111-118.
SACKS JJ, et al. 2010 National and state costs of excessive alcohol consumption. Am J Prev Med. 2015; 49: 452-463.
SEVEREIJNS NR, et al. Absenteeism, presenteeism, and the economic costs of alcohol hangover in The Netherlands. Healthcare. 2024; 12: 78-84.
SUDHINARASET M, et al. Social and Cultural Contexts of Alcohol Use: Influences in a Social-Ecological Framework. Alcohol Res. 2016; 38(1): 35-45.
TELLEZ-MONNERY K, et al. Proceedings of the 12th alcohol hangover research group meeting, in Buenos Aires, Argentina. AHRG Meeting. 2022; 1: 61-73.
THAVORNCHAROENSAP M, et al. The economic impact of alcohol consumption: a systematic review. Subst Abuse Treat Prev Policy, 2009; 3: 64 – 81.
VERSTER JC, et al. The Alcohol Hangover Research Group: ten years of progress in research on the causes, consequences, and treatment of the alcohol hangover. J Clin Med. 2020; 9: 569-587.
VERSTER JC, et al. The effects of SJP-001 on alcohol hangover severity: a pilot study. J Clin Med. 2020; 9: 932-936.
VERSTER JC, et al. Updating the definition of the alcohol hangover. J Clin Med. 2020; 9: 823-834.
XU, Y et al. The socioeconomic gradient of alcohol use: an analysis of nationally representative survey date from 55 low-income and middle-income countries. The Lancet Global Health. 2022; 10 (9): 1268 – 1280.
